Journal List > J Korean Med Sci > v.36(38) > 1147514

Ha, Cha, Yoo, Lee, Lee, and Koo: Effect of Dementia on Postoperative Mortality in Elderly Patients with Hip Fracture

Abstract

Background

The aim of this study was to assess the prevalence of dementia as an underlying disease in elderly patients with hip fracture, to investigate the effect of dementia on postoperative mortality after surgery of hip fracture, and to analyze the differences in postoperative mortalities according to the severity of dementia through subgroup analysis.

Methods

This study selected 2,346 elderly patients who were diagnosed with unilateral intertrochanteric or femoral neck fractures who underwent surgery between January 2004 and December 2018. The patients were classified into the non-dementia group (2,196 patients) and dementia group (150 patients; no-medication [66 patients] and medication [84 patients] subgroups). The cumulative crude mortality rate was calculated, and 30-day, 60-day, 3-month, 6-month, and 1-year mortality rates were compared between the groups. A univariate regression test was performed using age, sex, diagnosis, surgery type, and Charlson's comorbidity index (CCI), as these variables had P values of < 0.10. Multivariate regression analysis was performed to identify independent risk factors associated with mortality.

Results

The 30-day, 60-day, 3-month, 6-month, and 1-year postoperative cumulative mortality rates were 1.8%, 3.8%, 5.6%, 8.9%, and 13.6%, respectively, in the non-dementia group, and 2%, 7.3%, 14%, 19.3%, and 24%, respectively, in the dementia group (P = 0.748, P = 0.048, P < 0.001, P < 0.001, and P = 0.001). The factors that affected the 1-year mortality were age (odds ratio [OR], 1.06; 95% confidence interval [CI], 1.02–1.08; P < 0.001), sex (OR, 2.68; 95% CI, 2.07–3.47; P < 0.001), CCI (OR, 1.34; 95% CI, 1.23–1.47; P < 0.001), and dementia (OR, 1.70; 95% CI, 1.46–1.08; P = 0.016). In subgroup analysis, severity of dementia influenced the 6-month mortality (OR, 1.41; 95% CI, 1.70–2.01; P = 0.018), and 1-year mortality (OR, 1.30; 95% CI, 1.17–1.90; P = 0.027).

Conclusion

In elderly hip fracture patients, the comparison between patients with and without dementia revealed that dementia was an independent risk factor for mortality at a minimum of 1 year of follow-up, and the severity of dementia in hip fracture patients was a risk factor for mortality within 6 months and 1 year, postoperatively.

Graphical Abstract

jkms-36-e238-abf001.jpg

INTRODUCTION

Elderly hip fracture patients are well recognized owing to the serious socioeconomic burden and have high mortality rates and severe comorbidities.12 Factors related to postoperative mortality after hip fracture have been reported, such as male sex, high American Academy of Anesthesiology grade, older age, residence in an institution, comorbidities such as ischemic heart disease, malignancy and diabetes, and dementia.345
Dementia is one of the major factors that increases hip fracture risk and is one of the major cognitive impairment-related diseases along with delirium and Parkinson's disease.6 Recently, dementia has raised concerns because its incidence is increasing in many countries with aging global population.78910 In 2000, the number of dementia patients worldwide reached 25.5 million and the prevalence of dementia is expected to increase by 14–28% per decade.11 Dementia is not an urgent disease such as angina, pulmonary embolism, and pneumonia, thus, there is not much access to mortality data after hip fracture. In addition, studies on the effect of dementia on mortality after hip fracture have reported different results, and there are no reports on the postoperative mortality according to the severity of dementia.612
The aim of this study was to assess the prevalence of dementia as an underlying disease in elderly patients with hip fractures, to investigate the effect of dementia on postoperative mortality after hip fracture surgery, and to analyze the difference in postoperative mortality according to severity of dementia with or without anti-dementia medication through subgroup analysis.

METHODS

This retrospective study selected 2,869 (3,048 hips) patients who were diagnosed with unilateral intertrochanteric or femoral neck fractures and underwent surgery at one of two hospitals between January 2004 and December 2018. The exclusion criteria were as follows: 1) inappropriate medical records: 138 patients, 2) past surgery history of ipsilateral or contralateral lower extremity: 367 patients, 3) under 65 years old: 145 patients, 4) patients with multiple fractures: 42 patients, and 5) pathologic fractures: 10 patients (Fig. 1). The remaining 2,346 patients (2,346 hips) were classified into the non-dementia group (2,196 patients) and the dementia group (150 patients). The dementia group consisted of patients who were diagnosed by a psychiatrist and were undergoing follow-up. The severity of dementia was classified according to the use of anti-dementia medication.13 In subgroup analysis, 191 patients in the dementia group were classified into no-medication (66 patients) and medication (84 patients) subgroups.
Fig. 1

Flowchart for the recruitment of the study subjects.

jkms-36-e238-g001
Demographic data, including age, sex, diagnosis (intertrochanteric or femoral neck fracture), right/left, medical comorbidities on the basis of the modified Charlson's comorbidity index (CCI),14 time of surgical delay (from trauma to operation), surgery type (arthroplasty or internal fixation), anesthesia type (spinal or general), presence of intensive care unit (ICU) admission, and 30-day, 60-day, 3-month, 6-month, and 1-year mortality rates, were obtained by radiological findings and reviewing medical records.
Routine follow-up visits were scheduled at 6, 12 weeks, 6, 9, and 12 months; and every year thereafter. Patients who were unable to undergo follow-up evaluations were interviewed via telephone. Clinical information was collected by two nurses and an orthopedic surgeon. Mortality was determined by interviewing patients' families and/or using hospital records. A search for death certificates at the National Statistical Office was performed in patients who were lost to follow-up.

Statistical analysis

The 30-day, 60-day, 3-month, 6-month, and 1-year cumulative crude mortality rates were analyzed and compared between the non-dementia and dementia group.
Age, sex, fracture type, anesthesia type, duration of surgical delay, CCI, presence of ICU admission, presence of dementia, and dementia severity were assessed to determine the relationship with mortality. We used the chi-square test for categorical variables and Student's t-test for numerical variables. Statistical significance was set at P < 0.05. A univariate regression test was performed using age, sex, anesthesia type, medical comorbidities based on the CCI, surgery type, presence of dementia, and dementia severity, as these variables had P values < 0.10. Multivariate regression analysis was performed to identify independent risk factors associated with mortality. Statistical analysis was conducted using IBM SPSS Statistics (version 20.0, IBM, Chicago, IL, USA).

Ethics statement

The design and protocol of this study were approved by the Institutional Review Board (IRB) of Daejeon Eulji Medical Center (EMC-IRB No. 2020-01-005). The requirement of written informed consent was waived owing to the retrospective nature of the study.

RESULTS

Of the 2,346 patients with hip fractures, 150 (6.4%) patients were diagnosed with dementia. The 30-day, 60-day, 3-month, 6-month, and 1-year postoperative cumulative mortality rates were 1.8%, 3.8%, 5.6%, 8.9%, and 13.6%, respectively, in the non-dementia group, and 2%, 7.3%, 14%, 19.3%, and 24%, respectively, in the dementia group (Table 1, Fig. 2). The dementia group was older (P = 0.010), had a higher proportion of women (P = 0.034), worse CCI (P < 0.001), and higher prevalence of general anesthesia (P = 0.001).
Table 1

Summary of characteristics between non-dementia and dementia groups

jkms-36-e238-i001
Characteristics Non-dementia group (n = 2,196) Dementia group (n = 150) P value
Age ± SD, yr 81.80 ± 8.03 83.53 ± 6.44 0.010
Gender (man:woman) 587 (26.7):1,609 (73.3) 28 (18.7):122 (81.3) 0.034
Diagnosis (neck/intertrochanter) 978 (44.5):1,218 (55.5) 66 (44):84 (56) 0.932
Right side/left side 1,065 (48.7):1,123 (51.3) 77 (51.3):73 (48.7) 0.418
CCI ± SD 4.50 ± 1.29 5.74 ± 1.35 < 0.001
Surgical delay, days 3.66 ± 10.85 3.49 ± 3.07 0.186
Type of surgery (IF/arthroplasty) 1,239 (56.4):957 (43.6) 97 (64.7):53 (35.3) 0.050
Type of anesthesia (general/spinal) 1,042 (47.4):1,154 (52.6) 93 (62):57 (38) 0.001
Presence of ICU admission (o:x) 42 (1.9):2,154 (98.1) 2 (1.3):148 (98.7) 1.000
30-day mortality 39 (1.8) 3 (2) 0.748
60-day mortality 83 (3.8) 11 (7.3) 0.048
3-mon mortality 122 (5.6) 21 (14) < 0.001
6-mon mortality 196 (8.9) 29 (19.3) < 0.001
1-yr mortality 298 (13.6) 36 (24) 0.001
Data are presented as mean ± SD or number (%).
SD = standard deviation, CCI = Charlson comorbidity index, IF = internal fixation, ICU = intensive care unit.
Fig. 2

The graph shows the mortality rates of each group.

jkms-36-e238-g002
To analyze the risk factors for the 30-day, 60-day, 3-month, 6-month, and 1-year mortality in elderly patients with hip fractures, multivariable logistic regression was performed (Table 2). Age (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.03–1.12; P < 0.001) was identified as a factor that affected the 30-day mortality, and age (OR, 1.07; 95% CI, 1.04–1.10; P < 0.001), sex (OR, 2.64; 95% CI, 1.71–4.07; P < 0.001), CCI (OR, 1.28; 95% CI, 1.10–1.48; P = 0.001), and dementia (OR, 1.68; 95% CI, 1.34–2.35; P < 0.001) were identified as factors that affected the 60-day mortality. The factors that affected the 3-month mortality were age (OR, 1.08; 95% CI, 1.05–1.10; P < 0.001), sex (OR, 2.19; 95% CI, 1.51–3.16; P < 0.001), CCI (OR, 1.25; 95% CI, 1.10–1.42; P = 0.001), and dementia (OR, 1.48; 95% CI, 1.28–1.81; P = 0.006). The factors that affected the 6-month mortality were age (OR, 1.07; 95% CI, 1.05–1.09; P < 0.001), sex (OR, 2.25; 95% CI, 1.66–3.04; P < 0.001), CCI (OR, 1.28; 95% CI, 1.16–1.42; P < 0.001), and dementia (OR, 1.54; 95% CI, 1.34–1.86; P = 0.009). The factors that affected the 1-year mortality were age (OR, 1.06; 95% CI, 1.02–1.08; P < 0.001), sex (OR, 2.68; 95% CI, 2.07–3.47; P < 0.001), CCI (OR, 1.34; 95% CI, 1.23–1.47; P < 0.001), and dementia (OR, 1.70; 95% CI, 1.46–1.08; P = 0.016).
Table 2

Risk factors affecting postoperative mortality in elderly hip fracture patients

jkms-36-e238-i002
Variables 30-day mortality 60-day mortality 3-mon mortality 6-mon mortality 1-yr mortality
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Age 1.08 (1.03–1.12) < 0.001 1.07 (1.04–1.10) < 0.001 1.08 (1.05–1.10) < 0.001 1.07 (1.05–1.09) < 0.001 1.06 (1.02–1.08) < 0.001
Sex 1.91 (0.996–3.65) 0.051 2.64 (1.71–4.07) < 0.001 2.19 (1.51–3.16) < 0.001 2.25 (1.66–3.04) < 0.001 2.68 (2.07–3.47) < 0.001
CCI 1.18 (0.93–1.48) 0.171 1.28 (1.10–1.48) 0.001 1.25 (1.10–1.42) 0.001 1.28 (1.16–1.42) < 0.001 1.34 (1.23–1.47) < 0.001
Type of anesthesia 1.51 (0.80–2.85) 0.204 1.36 (0.88–2.10) 0.168 1.20 (0.84–1.71) 0.316 1.05 (0.78–1.40) 0.765 1.24 (0.97–1.88) 0.092
Type of surgery 1.10 (0.04–3.22) 0.138 1.20 (0.78–1.85) 0.412 1.32 (0.92–1.90) 0.127 1.35 (0.73–1.86) 0.130 1.41 (0.94–1.88) 0.103
Dementia 1.19 (0.35–4.01) 0.781 1.68 (1.34–2.35) < 0.001 1.48 (1.28–1.81) 0.006 1.54 (1.34–1.86) 0.009 1.70 (1.46–1.08) 0.016
OR = odds ratio, CI = confidence interval, CCI = Charlson comorbidity index.
In the subgroup analysis, among the 150 patients with dementia, the 30-day and 60-day, 3-month, 6-month, and 1-year postoperative cumulative mortality rates were 1.1%, 4.5%, 9.1%, 12.1%, and 15.2%, respectively, in the no-medication subgroup (66 patients), and 2.4%, 9.5%, 17.9%, 19.3%, and 31%, respectively, in the medication subgroup (84 patients) (Table 3, Fig. 2).
Table 3

Summary of characteristics of dementia patients in the no-medication group and medication group

jkms-36-e238-i003
Characteristics No-medication group (n = 66) Medication group (n = 84) P value
Age ± SD, yr 83.62 ± 6.89 83.46 ± 6.11 0.885
Gender (man:woman) 12 (18.2):54 (81.8) 16 (19):68 (81) 1.000
Diagnosis (neck/intertrochanter) 28 (42.4):38 (57.6) 38 (45.2):46 (54.8) 0.743
Right side/left side 35 (53):31 (47) 42 (50):42 (50) 0.744
CCI ± SD 5.50 ± 1.37 5.093 ± 1.36 0.052
Surgical delay, days 3.67 ± 2.41 3.34 ± 3.51 0.508
Type of surgery (IF/arthroplasty) 40 (60.6):26 (39.4) 57 (67.9):27 (32.1) 0.392
Type of anesthesia (general/spinal) 48 (66.3):18 (33.7) 45 (48.4):39 (51.6) 0.018
Presence of ICU admission (o:x) 1 (1.5):65 (98.5) 1 (1.2):83 (98.7) 1.000
30-day mortality 1 (1.1) 2 (2.4) 1.000
60-day mortality 3 (4.5) 8 (9.5) 0.348
3-mon mortality 6 (9.1) 15 (17.9) 0.096
6-mon mortality 8 (12.1) 21 (19.3) 0.036
1-yr mortality 10 (15.2) 26 (31.0) 0.034
Data are presented as mean ± SD or number (%).
SD = standard deviation, CCI = Charlson comorbidity index, IF = internal fixation, ICU = intensive care unit.
To analyze the risk factors for the 30-day mortality in elderly dementia patients after hip fracture, adjusted multivariable analysis was conducted. The severity of dementia influenced the 6-month mortality (OR, 1.41; 95% CI, 1.70–2.01; P = s0.018) and 1-year mortality (OR, 1.30; 95% CI, 1.17–1.90; P = 0.027) (Table 4).
Table 4

Risk factors affecting postoperative mortality in dementia patients with hip fractures

jkms-36-e238-i004
Variables 30-day mortality 60-day mortality 3-mon mortality 6-mon mortality 1-yr mortality
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
CCI 1.89 (0.98–3.65) 0.057 1.83 (1.20–2.81) 0.005 1.70 (1.20–2.41) 0.003 1.55 (1.16–2.12) 0.006 1.49 (1.11–2.00) 0.009
Type of anesthesia 1.32 (0.10–17.05) 0.834 1.18 (0.30–4.65) 0.818 1.08 (0.39–3.01) 0.88 1.15 (0.47–2.80) 0.765 1.10 (0.48–2.50) 0.818
Dementia severity 0.83 (0.06–10.78) 0.885 0.557 (0.130–2.38) 0.429 1.46 (1.17–2.26) 0.131 1.41 (1.70–2.01) 0.018 1.39 (1.17–1.90) 0.027
OR = odds ratio, CI = confidence interval, CCI = Charlson comorbidity index.

DISCUSSION

Dementia is strongly associated with osteoporosis and osteoporotic fracture.15 In addition, cognitive impairment in dementia patients increases the risk of hip fracture.16 The principal findings of this study are that the prevalence of dementia in elderly patients with hip fractures is 6.39%. The factors that affected the 1-year mortality in elderly patients with hip fracture were age (OR, 1.06; 95% CI, 1.02–1.08; P < 0.001), sex (OR, 2.68; 95% CI, 2.07–3.47; P < 0.001), CCI (OR, 1.34; 95% CI, 1.23–1.47; P < 0.001), and dementia (OR, 1.70; 95% CI, 1.46–1.08; P = 0.016). In the subgroup analysis, the severity of dementia increased the mortality rate within 6 months and 1 year postoperatively.
In a retrospective study of the Taiwan National Health Insurance Research Database, Lai et al.17 investigated the incidence of dementia according to surgery type in geriatric hip fractures and found that the prevalence of dementia was 5.24% in the internal fixation group and 5.29% in the hemiarthroplasty group. Ruggiero et al.18 analyzed the effect of delirium on mortality rates after surgery for a hip fracture and reported that 19.8% of patients had dementia as an underlying preoperative disease. In a retrospective cohort study in the Netherlands, 30% of 566 hip fracture patients over 70 years of age had dementia. In our study, the prevalence of dementia in elderly with hip fractures was 6.39%. The difference in prevalence of dementia in elderly hip fractures might be related to differences in demographic characteristics including age, sex proportion, comordibidy, and race.19
Most studies have consistently reported that dementia increases both long-term mortality and short-term mortality. In the study conducted by Lai et al.17, 8080 patients with dementia and 145,543 patients without dementia were enrolled. Dementia increased the 1-year (OR, 1.06; 95% CI, 1.00–1.13) and 2-year (OR, 1.10; 95% CI, 1.05–1.16) postoperative mortality risks in elderly patients with hip fractures. Bai et al.6 analyzed the postoperative mortality of dementia patients after a hip fracture in a meta-analysis of 18 cohort studies and reported that dementia increased the risk of mortality after hip fracture compared with that in non-dementia patients by 1.57, 1.97, and 1.77 times with respect to the 30-day, 6-month, and 1-year, mortality, respectively. In this study, the 60-day, 3-month, 6-month, and 1-year postoperative cumulative mortality rates in the dementia group were significantly higher than those in the non-dementia group. However, there was no difference in the 30-day mortality between the two groups. This might be related to dementia having a protective effect on in hospital mortality.17
In this study, the factors strongly related to the long-term mortality rate of dementia patients compared with non-dementia patients were age, sex, CCI and dementia. In particular, CCI was also associated with early mortality within 60 and 90 days postoperatively. We believed that pulmonary and cardiac comorbidities were the main factors contributing to the high mortality rate in the early postoperative period. Fansa et al.20 and Mitchell et al.21 reported that the main cause of this result was pulmonary and cardiac comorbidities. Delgado et al.22 investigated the influence of cognitive impairment on mortality of patients over 65 years with hip fractures and reported that dementia is a risk factor for pulmonary infections, urinary tract infection and sepsis. Barceló et al.23 assessed the causes of death in patients who died up to 2 years after hip fracture and found that circulatory system diseases and pneumonia were the most common causes of death. They also reported that decompression of chronic illness caused by hip fractures and the hip fracture itself were associated with death.
Our study had several limitations. First, the severity of dementia was only assessed by history of anti-dementia medication and this study did not consider the type of medication for dementia. Second, this retrospective study might have selection bias. However, we tried to minimize this bias in patient selection by using data from an electronic medical record and calculating the mortality rate based on a search for death certificates at the National Statistical Office. Third, the causes for death after hip fracture, such as medical comorbidities, were not considered. Thus, we used the CCI to minimize the effect of bias due to different medical comorbidities.
In elderly hip fracture patients, the comparison between patients with and without dementia showed that dementia was an independent risk factor of mortality at a minimum of 1-year of follow-up, and the severity of dementia in hip fracture patients was a risk factor for mortality within postoperative 6 months and 1 year postoperatively.

Notes

Funding: This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI19C0481, HC20C0157).

Disclosure: The authors have no potential conflicts of interest to disclose.

Authors Contributions:

  • Conceptualization: Ha YC.

  • Data curation: Cha YH.

  • Formal analysis: Yoo JI.

  • Investigation: Lee JY.

  • Methodology: Ha YC, Cha YH.

  • Validation: Lee YK.

  • Writing - original draft: Ha YC, Cha YH.

  • Writing - review & editing: Koo KH.

References

1. Cha YH, Ha YC, Yoo JI, Min YS, Lee YK, Koo KH. Effect of causes of surgical delay on early and late mortality in patients with proximal hip fracture. Arch Orthop Trauma Surg. 2017; 137(5):625–630. PMID: 28321571.
crossref
2. Park YG, Jang S, Ha YC. Incidence, morbidity and mortality in patients older than 50 years with second hip fracture in a Jeju cohort study. Hip Pelvis. 2014; 26(4):250–255. PMID: 27536589.
crossref
3. Hasegawa Y, Suzuki S, Wingstrand H. Risk of mortality following hip fracture in Japan. J Orthop Sci. 2007; 12(2):113–117. PMID: 17393264.
crossref
4. Ireland AW, Kelly PJ, Cumming RG. Risk factor profiles for early and delayed mortality after hip fracture: analyses of linked Australian Department of Veterans' Affairs databases. Injury. 2015; 46(6):1028–1035. PMID: 25813734.
crossref
5. Härstedt M, Rogmark C, Sutton R, Melander O, Fedorowski A. Impact of comorbidity on 6-month hospital readmission and mortality after hip fracture surgery. Injury. 2015; 46(4):713–718. PMID: 25627481.
crossref
6. Bai J, Zhang P, Liang X, Wu Z, Wang J, Liang Y. Association between dementia and mortality in the elderly patients undergoing hip fracture surgery: a meta-analysis. J Orthop Surg. 2018; 13(1):298.
crossref
7. Miller BL, Seeley WW, Mychack P, Rosen HJ, Mena I, Boone K. Neuroanatomy of the self: evidence from patients with frontotemporal dementia. Neurology. 2001; 57(5):817–821. PMID: 11552010.
crossref
8. Elahi FM, Miller BL. A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol. 2017; 13(8):457–476. PMID: 28708131.
crossref
9. Doblhammer G, Fink A, Fritze T. Short-term trends in dementia prevalence in Germany between the years 2007 and 2009. Alzheimers Dement. 2015; 11(3):291–299. PMID: 25301681.
crossref
10. Mathillas J, Lövheim H, Gustafson Y. Increasing prevalence of dementia among very old people. Age Ageing. 2011; 40(2):243–249. PMID: 21258087.
crossref
11. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord. 2003; 17(2):63–67. PMID: 12794381.
crossref
12. Chiu HC, Chen CM, Su TY, Chen CH, Hsieh HM, Hsieh CP, et al. Dementia predicted one-year mortality for patients with first hip fracture: a population-based study. Bone Joint J. 2018; 100-B(9):1220–1226. PMID: 30168771.
13. Jeong HG, Han C. Diagnosis and treatment of dementia in primary care. J Korean Med Assoc. 2013; 56(12):1104–1112.
crossref
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373–383. PMID: 3558716.
crossref
15. Chang KH, Chung CJ, Lin CL, Sung FC, Wu TN, Kao CH. Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr). 2014; 36(2):967–975. PMID: 24347180.
crossref
16. Draper B, Karmel R, Gibson D, Peut A, Anderson P. The Hospital Dementia Services Project: age differences in hospital stays for older people with and without dementia. Int Psychogeriatr. 2011; 23(10):1649–1658. PMID: 21902861.
crossref
17. Lai YC, Tang PL, Kuo TJ, Hsu CJ. Different impacts of dementia on two-year mortality after osteosynthesis and hemiarthroplasty in treating geriatric hip fractures. Arch Gerontol Geriatr. 2018; 79:116–122. PMID: 30196144.
crossref
18. Ruggiero C, Bonamassa L, Pelini L, Prioletta I, Cianferotti L, Metozzi A, et al. Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons. Osteoporos Int. 2017; 28(2):667–675. PMID: 27717957.
crossref
19. Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimers Dement. 2017; 13(1):72–83. PMID: 27599209.
crossref
20. Fansa A, Huff S, Ebraheim N. Prediction of mortality in nonagenarians following the surgical repair of hip fractures. Clin Orthop Surg. 2016; 8(2):140–145. PMID: 27247737.
crossref
21. Mitchell R, Harvey L, Brodaty H, Draper B, Close J. Hip fracture and the influence of dementia on health outcomes and access to hospital-based rehabilitation for older individuals. Disabil Rehabil. 2016; 38(23):2286–2295. PMID: 26765956.
crossref
22. Delgado A, Cordero G-G E, Marcos S, Cordero-Ampuero J. Influence of cognitive impairment on mortality, complications and functional outcome after hip fracture: Dementia as a risk factor for sepsis and urinary infection. Injury. 2020; 51(Suppl 1):S19–S24. PMID: 32067771.
crossref
23. Barceló M, Torres OH, Mascaró J, Casademont J. Hip fracture and mortality: study of specific causes of death and risk factors. Arch Osteoporos. 2021; 16(1):15. PMID: 33452949.
crossref
TOOLS
Similar articles